Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial-Reference-Cited by-同舟云学术

Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial

Published:2015-10 Issue:4 Volume:170 Page:669-674
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Geller Bram J.,Giugliano Robert P.,Braunwald Eugene,Murphy Sabina A.,Hanyok James J.,Jin Jianqing,Mercuri Michele,Antman Elliott M.,Ruff Christian T.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2. The history of atrial fibrillation: the last 100 years;Prystowsky;J Cardiovasc Electrophysiol,2008

3. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study;Heeringa;Eur Heart J,2006

4. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study;Go;JAMA,2001

5. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AVALIAÇÃO DA EFICÁCIA DAS NOVAS TERAPIAS ANTICOAGULANTES ORAIS NA PREVENÇÃO DE EVENTOS RELACIONADOS À FIBRILAÇÃO ATRIAL: UMA REVISÃO BIBLIOGRÁFICA;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-05-09

2. Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease;Frontiers in Cardiovascular Medicine;2021-12-23

3. Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation;American Journal of Therapeutics;2020-05

4. Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis;Cardiovascular Therapeutics;2020-04-25

5. Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation;Annals of Internal Medicine;2018-10-30